2021622
CongressKikuo Yasui, COO speaks at the International Society for Stem Cell Research (ISSCR) 2021, “Driving Change in Regenerative Medicine Through Global Partnerships: Organized by Novo Nordisk Stem Cell R&D”
2021615
CongressKeiichi Fukuda, CEO gave a presentation titled “Clinical Application of Human iPS Cell-Derived Ventricular Cardiomyocytes for Heart Failure Treatment” at Deep Tech in Asia: Stem Cell Innovations by SGInnovate.